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ABSTRACT
The role of cellular phosphatidylinositol 5-phosphate
(PtdIns5P), as a signalling molecule or as a substrate for the
production of small, compartmentalized pools of phospha-
tidylinositol 4,5-bisphosphate [PtdIns(4,5)P2], may be de-
pendent on cell type and subcellular localization. PtdIns5P
levels are primarily regulated by the PtdIns5P 4-kinases
(type II PIP kinases or PIP4Ks), and we have investigated the
expression and localization in the brain of the least-studied
PIP4K isoform, PIP4K. In situ hybridization and immuno-
histochemistry, using antisense oligonucleotide probes and
a PIP4K-speciﬁc antibody, revealed that this isoform has a
restricted CNS expression proﬁle. The use of antibodies to
different cell markers showed that this expression is limited
to neurons, particularly the cerebellar Purkinje cells, pyra-
midal cells of the hippocampus, large neuronal cell types in
the cerebral cortex including pyramidal cells, and mitral
cells in the olfactory bulb and is not expressed in cerebellar,
hippocampal formation, or olfactory bulb granule cells. In
neurons expressing this enzyme, PIP4K has a vesicular
distribution and shows partial colocalization with markers
of cellular compartments of the endomembrane trafﬁcking
pathway. The PIP4K isoform expression is established af-
ter day 7 of postnatal development. Overall, our data sug-
gest that PIP4K may have a role in neuron function, spe-
ciﬁcally in the regulation of vesicular transport, in speciﬁc
regions of the developed brain. J. Comp. Neurol. 517:
296–312, 2009. © 2009 Wiley-Liss, Inc.
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Polyphosphoinositides (PIs) are emerging as important con-
tributors to many physiological functions in cells and, as minor
phospholipid components of cellular membranes, have impor-
tant roles in signalling pathways. These are involved in diverse
functions such as cell migration and proliferation, ion channel
regulation, and membrane trafﬁcking (for reviews see Di Paolo
and De Camilli, 2006; Gamper and Shapiro, 2007; Irvine, 2003;
Pendaries et al., 2005; Suh and Hille, 2005; Yin and Janmey,
2003).
The canonical pathway to the production of phosphatidyl-
inositol 4,5-bisphosphate [(PtdIns(4,5)P2] in the cellular PI-
cycle involves the 5-kinase activity of the type I PtdInsP ki-
nases (PIP5Ks) using phosphatidylinositol 4-phosphate
(PtdIns4P) as substrate (Ishihara et al., 1998). However, since
the discovery of phosphatidylinositol 5-phosphate (PtdIns5P)
in cells (Rameh et al., 1997), another potential route has been
found via the 4-kinase activity of type II PtdInsP kinases (here
referred to as PIP4Ks, consistent with their substrate speci-
ﬁcity, although it should be noted that gene nomenclature still
refers to them as PIP5K2s). The PIP4Ks are present as , ,
and  isoforms in vertebrates, and there is evidence that each
isoform has a speciﬁc compartmentalization in cells that
could be intrinsic to its function. PIP4K is present in the
nucleus (Bunce et al., 2008; Ciruela et al., 2000; Richardson et
al., 2007), where it may be involved in stress responses
(Gozani et al., 2003; Jones et al., 2006; Zou et al., 2007).
PIP4K, the most active isoform, is predominantly cytosolic
(Hinchliffe et al., 1999; Wilcox and Hinchliffe, 2008) and can be
recruited to the plasma membrane by interaction with a PIP5K
(Hinchliffe et al., 2002).
The regulation of PtdIns(4,5)P2 levels in the brain has been
associated with numerous diseases, such as cancer, bipolar
disorder, and channelopathies (for reviews see Endersby and
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phoinositide regulation of a wide variety of neuronal ion trans-
porters (Gamper and Shapiro, 2007; Suh and Hille, 2005) sug-
gests that aberrant PtdIns(4,5)P2 metabolism may be involved
in epilepsy and Alzheimer’s disease (Jentsch et al., 2004;
Landman et al., 2006) and may contribute to symptoms of
Down’s syndrome (Voronov et al., 2008). Speciﬁc genetic mu-
tations have also linked PIP4K with schizophrenia (Fe-
dorenko et al., 2008), and disruption of the PIP5K2B gene is a
common feature in neuroblastoma (Schleiermacher et al.,
2005). All of the PIP4K and PIP5K isoforms are expressed in
the brain (Akiba et al., 2002), and the PIP5K splice variants
have been most extensively studied, having a major role in
synaptic vesicle cycling (Di Paolo et al., 2004; Nakano-
Kobayashi et al., 2007; Wenk et al., 2001). PIP5K is also
involved in neuronal maintenance (Giudici et al., 2004), devel-
opment and migration (Coulson et al., 2008; Wang et al.,
2007), and neurite remodelling (van Horck et al., 2002), sug-
gesting that polyphosphoinositides play signiﬁcant roles in
both neurogenesis and neuronal function, including learning
and memory. The observed interaction of PIP4K and PIP5K
isoforms (Hinchliffe et al., 2002) may also result in the recruit-
ment of speciﬁc PIP4Ks required to maintain distinct phos-
phoinositide pools within different cellular compartments.
The PIP4K isoform has not yet been associated with a
cellular function and is expressed predominantly in the kidney
and brain (Akiba et al., 2002; Clarke et al., 2008; Itoh et al.,
1998). In the present study, we have extensively investigated
the localization of PIP4K in the brain by using a speciﬁc
antibody to this isoform and found that it is remarkably con-
ﬁned to speciﬁc neuronal populations, where it is localized to
vesicular structures. Developmental studies imply that this
enzyme may be involved in neuronal function rather than in
neurogenesis. Overall, our results suggest that PIP4K may
have a specialized function in vesicle trafﬁcking in speciﬁc
neuronal cells.
MATERIALS AND METHODS
PIP4K cloning and expression
The PIP5K2C gene was ampliﬁed from a whole human brain
marathon-ready cDNA library (Clontech, Mountain View, CA)
and cloned into the plasmid expression vectors pET-32a (No-
vagen, Madison, WI) and pEGFP-C1 (Clontech) as previously
described (Clarke et al., 2008). Full-length recombinant
PIP4K was obtained by enterokinase cleavage of protein
puriﬁed by TALON metal afﬁnity resin (Clontech) from cell
culture lysates of Escherichia coli BL21(DE3)pLysS trans-
formed with the bacterial expression construct.
Endotoxin-free pEGFP-C1 plasmid constructs, puriﬁed from
bacterial clones (Qiagen puriﬁcation kit, Huntsville, AL), were
used for eukaryotic expression. HeLa cells, maintained in
DMEM (Gibco, Paisley, United Kingdom) supplemented with
10% fetal bovine serum, 50 U/ml penicillin, and 50 g/ml
streptomycin were transiently transfected for 24 hours using
TransFectin reagent (Bio-Rad, Hercules, CA), following the
manufacturer’s protocol.
Tissue preparation
Animal care was in accordance with institutional and na-
tional guidelines, and all procedures were performed in ac-
cordance with Home Ofﬁce guidelines, Animals (Scientiﬁc
Procedures) Act of 1986 under Home Ofﬁce Project licence
80/1747. Samples were collected from P1, P7, P14, P21, P28,
and adult male CD1 mice. Tissues used for cDNA library
construction and Western blotting lysates were collected
post-mortem from six animals and immediately frozen on dry
ice. For imaging experiments, brains were removed from three
mice that had been terminally anesthetized intraperitoneally
with sodium pentobarbital and perfused transcardially with
phosphate-buffered saline followed by 4% paraformaldehyde
(PFA) in 0.1 M phosphate buffer, pH 7.4. After cryoprotection
in 0.1 M phosphate buffer with 30% sucrose, brains were
stored at –80°C.
RT-PCR and in situ hybridization
Full-length mRNA was extracted as described previously
(Clarke et al., 2008), and cDNA libraries were made for each
tissue by reverse transcription (Sprint Powerscript kit; Clon-
tech). PCR ampliﬁcation was performed with Taq DNA poly-
merase (Invitrogen, Paisley, United Kingdom) and primers
speciﬁc to PIP5K2A (forward: 5-AAGAGTCTGATGCCAAGAA-
CCTGT-3 and reverse: 5-TGCAGTGCAACTTAAGGATGGTAA-
3), PIP5K2B (forward: 5-CATCCTCACAGAAGAACATGGC-3
and reverse: 5-CCTGGTCATTCACCGTCTCA-3), PIP5K2C (for-
ward: 5-CATCTTCCACTGCTAATGTGTCTCC-5 and reverse:
5-TTGAGTTATGGCTCTGACTCCTCTCT-3), and -actin (for-
ward: 5-GACGATATCGCTGCGCTGGT-3 and reverse: 5-
CCACGATGGAGGGGAATA-3), generating PCR products of
108, 104, 95, and 100 bp, respectively. Reactions were cycled
30 times (96°C for 1 minute, 60°C for 1 minute, 72°C for 3
minutes) on a Techne Progene thermal cycler and the prod-
ucts analyzed by 2% (w/v) agarose gel electrophoresis.
For in situ hybridization, two oligonucleotide probes for
PIP5K2C were 3-tail labeled with [
35S]dATP (NEN, Hounslow,
United Kingdom), hybridized with 20-m mouse tissue sec-
tions, and autoradiographed for 5 weeks, as previously de-
scribed (Giudici et al., 2004). Results for the probe designed to
the 3-untranslated region (5-GACTGGGTGGATTGAGTT-
ATGGCTCTGACTCCTCT-3) were conﬁrmed with the probe
designed to the coding sequence (5-ATAGGAGATAAGGAA-
ACGGCCATCACTGCCTTCAG-3). Both probes identiﬁed only
PIP5K2C when BLAT searched (Kent, 2002) against the EMBL
mouse database. Slides were treated with autoradiographic
emulsion and counterstained with methyl blue after develop-
ment (12 weeks). Control incubations contained an excess of
unlabeled probe in addition to the labeled oligonucleotide.
Primary antibody characterization
PIP4K was detected using a custom rabbit polyclonal an-
tibody raised against a synthetic peptide representing amino
acids 333–352 from the variable region of murine PIP4K. This
antibody speciﬁcally stains puriﬁed recombinant PIP4K pro-
tein and a 47-kDa molecular weight band from mouse brain by
Western blotting, and this signal is abolished in blotting and
immunochemistry experiments by preincubation with excess
antigenic peptide (this study; Clarke et al., 2008). Mouse
monoclonal antibody to -tubulin (Sigma-Aldrich, Gillingham,
United Kingdom; catalog No. T9026, lot No. 093K4880) was
raised against puriﬁed chick brain tubulin and stains a single
band of 57-kDa molecular weight by Western blot (Blose et al.,
1984). Mouse anti-calbindin D-28k monoclonal antibody
[Swant, Bellinzona, Switzerland; code No. 300, lot No. 07(F)]
was raised against puriﬁed chicken duodenum calbindin
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band of 28 kDa by Western blot, and no speciﬁc immunohis-
tochemical staining is seen in the brain of a calbindin D-28k
knockout mouse (manufacturer’s technical information). Anti-
parvalbumin mouse monoclonal antibody [Swant; code No.
235, lot No. 10-11(F)] was raised against puriﬁed carp muscle
parvalbumin (Celio et al., 1988). The antibody speciﬁcally
identiﬁes 12-kDa, IEF-4.9 parvalbumin by 2D immunoblot and
shows an absence of staining in the brain of a parvalbumin
knockout mouse (manufacturer’s technical information).
Mouse monoclonal antibodies to GM130, early endosome
antigen 1 (EEA1), and p115 (BD Transduction Laboratories,
Oxford, United Kingdom; catalog Nos. 610822, 610456, and
612260) were raised to amino acids 869–982 of rat GM130,
amino acids 3–281 of human EEA1, and amino acids 843–955
of rat p115, respectively. Each antibody stained a single band
in rat brain by Western blot (130-kDa, 180-kDa, and 115-kDa
molecular weights, respectively, by the manufacturer’s tech-
nical information) and showed representative staining as pre-
viously reported (Allan et al., 2000; Clarke et al., 2008). The
guinea pig polyclonal antibody against glial ﬁbrillary acidic
protein (GFAP; Advanced Immunochemical, Long Beach, CA;
catalog No. 031223) was raised against puriﬁed human GFAP,
and this antibody stained cells with the classic morphology
and distribution of ﬁbrous astrocytes in our experiments.
Mouse monoclonal anti-neuronal class III -tubulin (clone
TUJ1; Stem Cell Technologies Inc., Vancouver, British Colum-
bia, Canada; catalog No. 01409) was raised against rat brain
microtubules and speciﬁcally stained neuronal and not glial
cell -tubulin (manufacturer’s technical information). Mouse
monoclonal anti-KDEL antibody (Stressgen, Ann Arbor, MI;
catalog No. SPA-827) was raised against amino acids 649–
654 of rat Grp78 (BiP) and recognized Grp78 (78 kDa) and
Grp94 (94 kDa) bands in mouse brain by Western blot (man-
ufacturer’s technical information). Antibodies to golgin 160
(goat polyclonal), lysosome-associated membrane protein 1
(LAMP-1; mouse monoclonal), and LAMP-2 (rabbit polyclonal)
were from Santa Cruz Biotechnology (Santa Cruz, CA; catalog
Nos. sc-79966, sc-17768, and sc-5571, respectively). The an-
tibody to golgin 160 was raised against the 14 N-terminal
amino acids of human golgin 160 and stained cells with a
pattern previously observed (Hicks and Machamer, 2002).
Anti-LAMP antibodies were raised against amino acids 1–228
and 1–207 of human LAMP-1 and LAMP-2, respectively, and
stained single bands in cell lysates by Western blot (manufac-
turer’s technical information) and cells with a pattern previ-
ously observed (Saraﬁan et al., 1998). Mouse monoclonal anti-
Golgi 58K protein (Sigma; clone 58K-9; catalog No. G2404)
was raised against rat liver Golgi 58K protein, stained a single
58-kDa band in rat brain, and gave a characteristic Golgi
staining by immunoﬂuorescence (Bloom and Brashear, 1989).
A mouse monoclonal anti-calnexin antibody and rabbit poly-
clonal antibodies to catalase, mannose-6-phosphate recep-
tor, and mannosidase II were obtained from Abcam Ltd. (Cam-
bridge, United Kingdom; catalog Nos. ab31290, ab1877,
ab12894, and ab12277, respectively). Anti-calnexin was
raised to calnexin of human origin and stained cells with a
typical ER pattern (manufacturer’s technical information).
Anti-catalase antibody was raised against bovine liver cata-
lase and gave a single band of 65 kDa by Western blot in a
number of tissue lysates, as well as a characteristic peroxiso-
mal staining pattern (manufacturer’s technical information).
Antibodies to mannose-6-phosphate receptor (amino acids
700–800) and mannosidase II were raised against protein of
human origin and showed characteristic immunoﬂuorescent
staining patterns by the manufacturer’s technical information.
Western blotting
Whole mouse brains were dissected under a binocular mi-
croscope and separated into nine regions, and protein lysates
were prepared in RIPA buffer (150 mM sodium chloride, 50
mM Tris pH7.4, 1 mM EDTA, 1% Triton X-100, 1% deoxycholic
acid, 0.1% SDS) with 10 mM tetrasodium pyrophosphate, 10
mM sodium ﬂuoride, 17.5 mM -glycerophosphate, and 100
l/ml protease inhibitor cocktail (Sigma-Aldrich; catalog No.
P8340) as previously described (Clarke et al., 2008). Protein
samples were resolved by 8–10% SDS-PAGE, and Western
blots were carried out using antibodies to PIP4K (1:1,000) or
-tubulin (1:5,000). Horseradish peroxidase-conjugated sec-
ondary antibody (anti-rabbit IgG or anti-mouse IgG, 1:5,000)
and SuperSignal West Dura substrate (Pierce Protein Re-
search Products, Rockford, IL) were used to detect positive
signal via the manufacturer’s protocol. Samples were dephos-
phorylated by treatment with 1 unit calf intestinal alkaline
phosphatase (Promega, Madison, WI) per microgram protein
for 60 minutes at 37°C. PIP4K antibody for control blots was
preincubated with excess antigenic peptide for 30 minutes at
room temperature. Autoradiographic images were quantiﬁed
by comparing average integrated pixel intensities (Image J;
NIH, Bethesda, MD) for a deﬁned area with background sub-
traction. These values were normalized to the loading control.
Immunohistochemistry
Tissue was sectioned (20 m) on a cryostat (Leica, Wetzlar,
Germany) at –20°C and either mounted onto SuperFrost Plus
Gold slides (Menzel-Glaser, Braunschweig, Germany) and
stored at –80°C or stored as free-ﬂoating sections (0.1%
sodium azide in PBS) at 4°C. Sagittal and horizontal brain
sections for immunoperoxidase staining were pretreated for
20 minutes with 5% hydrogen peroxide in 20% methanol,
blocked for 2 hours (1% ﬁsh skin gelatin, 0.3% Triton X-100 in
PBS), and exposed to anti-PIP4K antibody (1:500, 24 hours
at 4°C). Detection was carried out with biotinylated anti-rabbit
IgG secondary antibody (1:200), Vectastain ABC reagent, and
DAB substrate (Vector Laboratories, Burlingame, CA). Free-
ﬂoating stained sections were mounted onto gelatinized
slides, air dried, and treated with ethanol (2 minutes in 70%
solution, 2 minutes in 95% solution, 3 minutes in 100%) and
then with Histoclear reagent (Sigma-Aldrich). Coverslips were
permanently mounted with DPX reagent (Sigma-Aldrich).
Brain sections for ﬂuorescent labeling experiments were
pretreated and incubated as previously described (Clarke et
al., 2008) using anti-PIP4K (1:750), anti-calbindin D-28k (1:
1,000), anti-parvalbumin (1:1,000), anti-GM130 (1:50), anti-
p115 (1:100), anti-TUJ1 (1:1,000), anti-calnexin (1:1,000), and
anti-GFAP (1:2,500). Fluorescent dye-conjugated secondary
antibodies (Alexa Fluor 488 anti-rabbit IgG and Alexa Fluor
546 anti-rabbit, anti-mouse, and anti-guinea pig IgG, 1:1,000;
Molecular Probes, Paisley, United Kingdom) were used for
ﬂuorescence microscopy. Whole sections for brain region ref-
erence were stained with 435/455 blue ﬂuorescent Nissl stain
(NeuroTrace; 1:300; Molecular Probes) with the manufactur-
er’s speciﬁcations. Coverslips were mounted with ProLong
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for controls was preincubated with 50 g of recombinant
protein for 30 minutes at room temperature. Brain areas were
identiﬁed by using a stereotactic atlas (Lein et al., 2007).
Immunocytochemistry
Primary hippocampal cultures were isolated and maintained
as a source of pyramidal neurons (Koizumi et al., 1999), and
primary cerebellar granule cells were isolated and maintained
as described by Giudici et al. (2004). These cells were derived
from rat brain, and PIP4K from this source is 98.1% similar at
the protein level and immunoreactive with the anti-PIP4K
antibody. Glass coverslips seeded with neuronal cultures or
transiently transfected HeLa cells expressing GFP-tagged
constructs were ﬁxed in 4% PFA for 30 minutes on ice. Cells
were permeabilized with 0.1% Triton X-100 in PBS for 10
minutes and blocked with 4% ﬁsh skin gelatin (Sigma-Aldrich)
in PBS for 30 minutes, then incubated for 60 minutes with
anti-PIP4K (1:1,000), anti-GM130 (1:50), anti-p115 (1:100),
anti-EEA1 (1:50), anti-mannose-6-phosphate receptor (1:500),
anti-GRP78 (1:250), anti-58K (1:250), anti-mannosidase II (1:
200), anti-golgin 160 (1:250), anti-catalase (1:200), anti-
LAMP-1 (1:250), anti-LAMP-2 (1:250), or anti-tubulin (1:400).
After incubation with secondary antibody (Alexa Fluor 488
anti-rabbit IgG and Alexa Fluor 546 anti-mouse or anti-goat
IgG in 2% gelatin in PBS) or Alexa Fluor 568-conjugated
phalloidin (Molecular Probes), coverslips were mounted onto
slides with ProLong Gold antifade reagent (Molecular Probes)
and analyzed as described below. For permeabilization ex-
periments, cells were treated (preﬁxation) with 20 g/ml dig-
itonin or 1% Triton X-100 for 5 minutes (in 80 mM PIPES pH
6.8, 4% PEG 8000, 1 mM MgCl2, 1 mM EGTA).
Microscopy and ﬁgure preparation
Light microscopy was performed with an Axioskop II micro-
scope (Carl Zeiss GmbH, Munich, Germany), and images were
saved as TIF format in AxioVision software (Carl Zeiss GmbH).
Confocal microscopy was carried out by sequential scanning
with a Leica TCS SP5 laser scanning confocal microscope
running LAS AF software (Leica Microsystems Ltd., Milton
Keynes, United Kingdom). Images were tinted and output as
TIF ﬁles from Image J.
Autoradiographic images developed from in situ hybridiza-
tion and electrophoresis gels were scanned and output as TIF
ﬁles by using a Hewlett-Packard scanjet 8200 scanner and
VueScan software (Hamrick Software, Pheonix, AZ). Figures
were prepared for publication in Adobe Photoshop (Adobe
Systems, San Jose, CA), adjusting image brightness and con-
trast only.
RESULTS
PIP5K2C has an expression proﬁle in mouse
brain
Previous studies have suggested that PIP5K2 isoforms are
differentially transcribed according to tissue (Akiba et al.,
2002; Clarke et al., 2008; Itoh et al., 1998), and RT-PCR with
isoform-speciﬁc primers conﬁrmed this (Fig. 1). Among the
tissues tested, PIP5K2A mRNA levels were comparatively
higher in mouse spleen, PIP5K2B levels were higher in mus-
cle, and PIP5K2C was the predominant isoform in kidney (this
study; Clarke et al., 2008). However, mRNA for each isoform
was also detected, at different levels, in brain (Fig. 1). Tissue
analysis by in situ hybridization with two different PIP5K2C
probes conﬁrmed that transcription of this isoform was up-
regulated in discrete regions of the brain, compared with a
control tissue (Fig. 2). Silver grain labeling of PIP5K2C mRNA
in brain suggested that expression was conﬁned to cells on
the boundary of the molecular and granular layers of the
cerebellum and in large cell bodies in the hippocampus (CA1–
CA3), cerebral cortex, and olfactory bulb (Fig. 2).
Endogenous PIP4K is expressed in speciﬁc
brain regions
With a polyclonal peptide antibody speciﬁc to the variable
region of PIP4K (Fig. 3; Clarke et al., 2008), our results
indicated that this PIP4K isoform is differentially expressed
within the mouse brain. Crude dissection of mouse brain
tissue and Western blotting of the protein lysates allowed
direct comparison of PIP4K levels in these regions. Equiva-
lent samples (by total protein loading) were standardized to
the loading control (-tubulin), and quantiﬁcation indicated
that PIP4K levels were higher in the cerebral cortex, hip-
pocampus, spinal cord, and olfactory bulb, with signiﬁcant
expression also seen in the cerebellum and brainstem (Fig. 4).
Tissue lysates from these regions were further investigated to
resolve multiple PIP4K-immunoreactive bands. Western
blotting of samples with comparative PIP4K levels indicated
the presence of three distinct bands at 47, 48, and 49 kDa (Fig.
5). The two lower molecular weight bands were present in all
of the six regions, whereas the 49-kDa band was equivalent in
the cerebellum and hippocampus; signiﬁcantly reduced in the
cortex, brainstem, and spinal cord; and completely absent
from the olfactory bulb (Fig. 5). Treatment of samples with
phosphatase removed the 48- and 49-kDa bands, suggesting
that these were phosphorylated forms of PIP4K (Fig. 5). Itoh
et al. (1998) previously identiﬁed one phosphorylated form of
PIP4K, and our results suggest that the presence of a third
immunoreactive band could indicate a form of the protein that
is speciﬁc to distinct areas of brain tissue, in contrast to other
tissues studied (Clarke et al., 2008).
Immunostaining of endogenous PIP4K in whole-brain sec-
tions allowed the further identiﬁcation of regions showing
Figure 1.
PIP5K2 gene expression in adult mouse tissue cDNA libraries. Com-
parative levels of PIP5K2A, PIP5K2B, PIP5K2C, and -actin control
mRNA in different tissues as determined by RT-PCR (representative of
results from cDNA libraries generated from three different animals).
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of sections, labeled with anti-PIP4K by immunochemical or
immunoﬂuorescent methods, indicated expression of this iso-
form in isolated cells (including pyramidal and basket cells)
throughout the cerebral cortical layers (Fig. 7A–C), and this
expression did not extend into the corpus callosum or cingu-
lum region or into the caudate-putamen. High levels of ex-
pression were seen in the hippocampal formation, primarily in
the stratum pyramidale and extending into the stratum radia-
tum of CA1–CA3, and were excluded from the dentate gyrus
(Fig. 7E–G). Within the cerebellar cortex, PIP4K was ob-
served in large cell bodies of the Purkinje layer, extending into
the dendritic trees of these cells, but was absent from the
granular layer (Fig. 7M–O). PIP4K expression was excluded
from the majority of the medulla (Fig. 8E–G) but was present in
the dorsal horn of the spinal cord (Fig. 8A–C) and the spinal
Figure 2.
PIP5K2C gene expression in adult mouse tissues by in situ hybridiza-
tion. With PIP5K2C-speciﬁc probes on 20-m mouse tissue sections,
positive signal is spatially distributed in brain (A) but absent from heart
tissue (C; not to scale). Control sections of brain (B) and heart (D) were
incubated with excess of unlabeled probe, and identical results were
obtained with three sections from two animals. Autoradiographic
emulsion staining of hybridization slides (counterstained with methyl
blue), shows PIP5K2C mRNA labeled with silver grains (E–J). Positive
cells (arrows) are seen in the cerebellum (E, inset is Purkinje cell layer),
hippocampal ﬁeld CA1 (F, inset is stratum pyramidale), cerebral cor-
tex (G, inset is layer V), and olfactory bulb (H, inset is mitral cell layer).
Controls incubated with excess cold probe (I,J) were negative. au,
Heart auricle; ve, heart ventricle; cm, molecular layer; cp, Purkinje
layer; cg, granular layer (all cerebellar); ho, stratum oriens; hp, stratum
pyramidale; hr, stratum radiatum (all hippocampal); op, outer plexi-
form layer; om, mitral cell layer; ip, inner plexiform layer; og, granule
cell layer (all olfactory bulb). Scale bars  40 m in E–I; 10 mi nJa n d
insets.
Figure 3.
Speciﬁcity of antiphosphatidylinositol 5-phosphate 4-kinase 
(PIP4K) antibody to PIP4K in mouse brain. A: SDS-PAGE of total
proteins from 50 g whole mouse brain lysate (Coomassie stained)
and 50 ng of puriﬁed recombinant (rec) PIP4K (silver stained) show-
ing mature protein of 47 kDa and degradation products at 26 kDa.
B: Western blot of these proteins using anti-PIP4K antibody, show-
ing single band speciﬁcity in brain lysate. C: Control Western blot
using anti-PIP4K antibody preincubated with antigenic peptide. Re-
sults are representative of at least three experiments.
Figure 4.
Endogenous PIP4K expression in adult mouse brain. Quantiﬁcation
of PIP4K levels in lysates (30 g) from 10 different adult mouse CNS
regions probed with PIP4K-speciﬁc antibody (n  3). Integrated pixel
intensities for each band are shown (SEM), normalized to the loading
control (-tubulin). Recombinant (rec) PIP4K was included as a pos-
itive size control.
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was also observed throughout the cervical, thoracic, and lum-
ber spinal cord regions (data not shown) and large neuronal
cell bodies in the dorsal root ganglia (see Fig. 12C). Lower
level expression was observed in the pontine gray, and the
remainder of the pons, midbrain, thalamus, and hypothalamus
were negative (Figs. 7I–K, 8I–K). In the olfactory bulb, PIP4K
expression was seen in cells extending from the mitral cell
layer to the olfactory nerve layer and into the anterior olfactory
nucleus but excluded from the granular cell layer (Fig. 8M–O).
Expression of PIP4K is restricted to speciﬁc
neurons
Further characterization of PIP4K-positive cells in the
adult mouse brain indicated that this phosphoinositide kinase
is preferentially expressed in cells that are costained with
neuronal cell markers (Figs. 9–11; Supp. Info. Figs. 1, 2). Use
of a ﬂuorescent counterstain to identify neurons by abun-
dance of Nissl substance (Quinn et al., 1995) colocalized
PIP4K to these cells in each region studied (Figs. 9C,F,O,R,
10C,L, 11C), and this was conﬁrmed by colocalization with the
neuronal class III -tubulin marker TUJ1 (Supp Info. Fig. 1).
PIP4K was not expressed in granule cells in the cerebellum
(Fig. 10C) or in the dentate gyrus (Fig. 9O). Costaining with an
antibody to the glial cell marker GFAP (Figs. 9I,U, 10F,O)
suggested that the PIP4K signal was excluded from these
cells. Furthermore, staining of pyramidal cell cultures (derived
from hippocampus) for endogenous PIP4K indicated that
these neurons were PIP4K positive (Fig. 11I), whereas pri-
mary cell cultures of granule cells (derived from cerebellum)
showed little endogenous signal (Fig. 11L). Within the cerebral
cortex, hippocampus, and olfactory bulb, the subset of neu-
rons expressing PIP4K was excluded from the subpopula-
tions expressing the calcium-binding protein calbindin D-28k
(Figs. 9L,X, 10R), and parvalbumin (Supp. Info. Fig. 2C,F,L), a
calcium-binding marker of GABAergic interneurons, which is
predominantly expressed by chandelier and basket cells in
the cortex (Hendry et al., 1989). In the cerebellum, both of
these markers were present in PIP4K-positive Purkinje cells
(Fig. 10I; Supp Info. Fig. 2I), and, within the spinal cord, the
population of PIP4K-positive neurons included subpopula-
tions positive for both calbindin D-28k (Fig. 11F) and parval-
bumin (Supp. Info. Fig. 2O).
PIP4K has a distinct subcellular
compartmentalization
Confocal microscopy at high resolution and costaining with
a range of markers for different subcellular compartments
allowed the identiﬁcation of a distinct vesicular location for
PIP4K. In all of the neurons observed expressing PIP4K,
endogenous signal was present in the cell body and dendritic
projections but was mostly excluded from the nucleus (Fig.
12). Subcellular localization was cytoplasmic and partially pe-
rinuclear, with clear, punctate staining (Fig. 12A–C), similar to
that observed in kidney cells (Clarke et al., 2008). Costaining
of endogenous PIP4K in brain tissue with markers for the
endoplasmic reticulum and Golgi apparatus suggested that
the vesicular PIP4K compartment might partially colocalize
with one of these structures (Fig. 12F,I,L).
To investigate this potential association in more detail,
HeLa cells were transiently transfected with constructs ex-
pressing PIP4K fused to the GFP reporter protein, because
very low endogenous levels of PIP4K were observed in neu-
ronal cell lines such as SH-SY5Y (data not shown). Cells were
permeabilized to reduce the levels of free cytosolic protein
produced by overexpression, as judged by the reduction of
overexpressed control GFP levels (Supp. Info. Fig. 3). Treat-
Figure 5.
Multiple forms of PIP4K are differentially expressed in brain regions.
A: PIP4K was detected as three different bands (47, 48, and 49 kDa)
by 8% SDS-PAGE and Western blotting. The 49-kDa band was differ-
entially expressed in cerebral cortex, hippocampus, spinal cord, cer-
ebellum, and brainstem and was not present in the olfactory bulb.
B: Only the 47-kDa band remained after lysates were pretreated with
calf intestinal alkaline phosphatase (CIAP) and Western blotted with
anti-PIP4K antibody. Results are representative of at least three
experiments.
Figure 6.
PIP4K expression in different regions of the adult mouse brain.
PIP4K was detected in whole saggital brain sections (approximately
lateral 0.48 mm) by immunoﬂuorescence with anti-PIP4K antibody
(A). Staining indicated differential expression levels of PIP4K in dif-
ferent brain regions. A similar, ﬂuorescent Nissl-stained section is
included for morphological reference (B). Images are representative of
a minimum of six stained sections from three different mice. Scale
bars  1 mm. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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cantly reduced cytosolic levels of GFP and all three PIP4K
isoforms, and stronger detergent extraction completely re-
moved GFP signal, but nuclear PIP4K and vesicular PIP4K
remained resistant to this procedure, suggesting a stronger
association with a cellular compartment (Supp. Info. Fig. 3). A
proportion of PIP4K remains localized to the nucleus during
extraction, which may also be signiﬁcant. Permeabilization
Figure 7.
A–P: Localization of PIP4K in adult mouse brain regions. Positive PIP4K signal (arrows) was observed in the cerebral cortex (A–C), CA1–CA3
of the hippocampus (E–G) and cerebellum (M–O). No signiﬁcant signal was observed in the inferior colliculus (I–K). Saggital brain sections were
stained by immunoﬂuorescent (A,B,E,F,I,J,M,N) and also immunochemical (C,G,K,O) methods. Fluorescent Nissl-stained images are included
for reference (D,H,L,P). Images are representative of a minimum of six stained sections from three different mice. I, II/III, V, cerebral cortex layers;
dg, dentate gyrus; py, hippocampal pyramidal cells; ec, external cortex of the inferior collicus; cn, central nucleus of the inferior collicus; ig,
intermediate gray layer of the superior collicus; pu, cerebellar Purkinje cells; g, cerebellar granular layer; m, cerebellar molecular layer. Scale
bars  100 m in A,E,I,M; 50 m in B,F,J,N; 20 m in C,G,K,O; 500 m in D,H,L,P. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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A–T: Localization of PIP4K in adult mouse brain regions. Positive PIP4K signal (arrows) was observed in the cervical spinal cord (longitudinal
section, A–C) and olfactory bulb (M–O). No signiﬁcant signal was observed in other areas such as the medulla (E–G) or thalamus (I–K). Saggital brain
sections were stained by immunoﬂuorescent (A,B,E,F,I,J,M,N,S,T) and also immunochemical (C,G,K,O,Q,R) methods. Fluorescent Nissl-stained
images are included for reference (D,H,L,P). Controls for immunochemical and immunoﬂuorescent labeling (incubated with secondary antibody only
or using preadsorbed anti-PIP4K) are also included (Q–T). Images are representative of a minimum of six stained sections from three different mice.
dw, Dorsal white matter of the spine; vw, ventral white matter of the spine; gr, spinal gray matter; ir, intermediate reticular nucleus of the medulla; mr,
medullary reticular nucleus; md, mediodorsal/paracentral thalamic nuclei; ad, anterodorsal thalamic nucleus; gl, olfactory glomerular layer; op,
olfactory outer plexiform layer; gr, olfactory granule cell layer; mi, olfactory mitral cells; g, cerebellar granular layer; m, cerebellar molecular layer. Scale
bars  100 m in A,E,I,M; 50 m in B,F,J,N; 20 m in C,G,K,O,Q–T; 500 m in D,H,L,P. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]Figure 9.
Identiﬁcation of cell types expressing PIP4K in the adult mouse cerebral cortex and hippocampus. Endogenous PIP4K was detected in cerebral cortex
(A–L) and hippocampus (M–X) by using anti-PIP4K antibody (green). Counterstaining for Nissl substance (B,E,N,Q) indicated that PIP4K was expressed
in neuronal cells (C,F,O,R). PIP4K was excluded from glial cells stained with anti-glial ﬁbrillary acidic protein (GFAP; G–I,S–U). PIP4K was not expressed
in cells that were positive for the neuronal cell marker calbindin D-28k in these regions (J–L,V–X). Images are representative of three stained sections. py,
Stratum pyramidale of hippocampus; dg, dentate gyrus. Scale bars  50 m in C (applies to A–C); 20 m in F (applies to D–F); 50 m in I (applies to G–I);
50 m in L (applies to J–L); 50 m in O (applies to M–O); 20 m in R (applies to P–R); 50 m in U (applies to S–U); 50 m in X (applies to V–X).Figure 10.
Identiﬁcation of cell types expressing PIP4K in the adult mouse cerebellum and olfactory bulb. PIP4K (green) was detected in the cerebellum
(A–I) and olfactory bulb (J–R). Signal was coincident with ﬂuorescent Nissl stain (A–C,J–L) and was excluded from glial cells stained with
anti-GFAP (D–F,M–O), indicating that PIP4K was expressed in neuronal cells. PIP4K was expressed in cells that were positive for the neuronal
cell marker calbindin D-28k in the cerebellum (G–I) but not in the olfactory bulb (P–R). Images are representative of three stained sections. gr,
Cerebellar granular layer; pu, cerebellar Purkinje layer; mi, mitral cell layer of olfactory bulb. Scale bars  50 m in C (applies to A–C); 50 m
in F (applies to D–F); 20 m in I (applies to G–I); 50 m in L (applies to J–L); 20 m in O (applies to M–O); 50 m in R (applies to P–R).Figure 11.
Identiﬁcation of cell types expressing PIP4K in the adult mouse spinal cord and in primary neuronal cultures. Endogenous PIP4K (green) was detected
in neurons in the spinal cord (A–F) by ﬂuorescent costaining for Nissl substance (A–C) and was also seen in the subpopulation of neurons positive for
calbindin D-28k (D–F). Hippocampal primary cell cultures enriched for pyramidal cells expressed PIP4K (G–I), whereas cultures enriched for cerebellar
granule cells did not (J–L). Images for (A–F) are representative of three stained sections. dw, Dorsal white matter of the spine; gr, spinal gray matter. Scale
bars  50 m in C (applies to A–C); 50 m in F (applies to D–F); 20 m in I (applies to G–I); 20 m in L (applies to J–L).Figure 12.
Subcellular localization of PIP4K in neurons. Endogenous PIP4K was detected in the cell body and dendritic trees of cerebellar Purkinje cells
(A), olfactory bulb mitral cells (B), and large neurons in dorsal root ganglion (drg) preparations (C). PIP4K was mostly excluded from the nucleus
and was present in a vesicular compartment in the cytoplasm. This compartment seemed to have a stronger, but partial, colocalization with the
cis-Golgi structural marker GM130 (J–L) than with the ER resident calnexin (D–F) or the -ergic marker p115 (G–I), although this could not be fully
characterized in brain tissue. Images are representative of results from at least three stained sections. Scale bars  20 m in A–C; 20 mi n
F (applies to D–F); 20 m in I (applies to G–I); 20 m in L (applies to J–L).did not affect the staining of other cellular compartment mark-
ers. PIP4K was not seen to colocalize with the endoplasmic
reticulum resident Grp78 (Supp. Info. Fig. 5C), in accordance
with previous observations (Clarke et al., 2008), or the -ergic
Golgi vesicle docking protein p115 (Fig. 13C). Partial colocal-
ization after digitonin treatment was observed with the Golgi
markers GM130 (Fig. 13F), 58K, mannosidase II, and golgin
160 (Supp. Info. Fig. 4) and the endosomal markers EEA1 and
mannose-6-phosphate receptor (Fig. 13I,L), but not the lyso-
somal markers LAMP-1 and LAMP-2 or the peroxisomal
marker catalase (Supp. Info. Fig. 5F,I,L). However, the PIP4K
protein remaining after stronger detergent treatment did not
completely localize to any of these compartments (Fig.
13O,R,U,X; Supp. Info. Fig. 6).
PIP4K expression during postnatal development
Examination of similar brain sections in a murine postnatal
developmental series indicated that the onset of PIP4K ex-
pression from neurons was between postnatal days 7 and 14
(Fig. 14). Establishment of Purkinje cells and deﬁned dendritic
trees in the Purkinje layer of the cerebellum was apparent at
P14, and staining for endogenous PIP4K indicated that this
enzyme was also expressed by Purkinje cells at this time.
Spaces in the Purkinje cell layer may be due to naturally
occurring neuronal cell death (Madalosso et al., 2005). Similar
results were observed for PIP4K expression in hippocampal
pyramidal cells and the mitral cell layer of the olfactory bulb
(Fig. 14).
DISCUSSION
Here we have investigated the expression of the PIP4K
isoforms in the murine brain, with speciﬁc reference to
PIP4K. We have further characterized the restricted localiza-
tion of this PIP4K in different regions of the brain, identiﬁed
the neuronal cells expressing the protein, and suggested a
subcellular compartmentalization that has implications for the
physiological function of this isoform.
PIP4K expression and neuronal localization
Gene expression proﬁles for the PIP5K2s, collated as
MIAME-compliant microarray data on the EMBL ArrayExpress
Warehouse database (Parkinson et al., 2007), support the
observations that there are tissue-speciﬁc differences in iso-
form abundance (Clarke et al., 2008). PIP4K is the most
abundant isoform in spleen and blood components, such as
platelets (Hinchliffe et al., 1998; Morris et al., 2000), whereas
PIP4K levels are enhanced in skeletal muscle (Castellino et
al., 1997), and PIP4K is most abundant in kidney (Clarke et
al., 2008; Itoh et al., 1998). However, all three PIP4K isoforms
are also transcribed in speciﬁc areas of the mammalian brain
but have different spatial distributions (Akiba et al., 2002), and
our in situ hybridization studies conform to the PIP5K2C gene
expression pattern reported in the Allen Brain Atlas (Lein et al.,
2007). Our detection of endogenous PIP4K protein in brain is
consistent with these transcription levels, and the results from
Western blotting of nine different brain regions concur with
the results obtained from immunohistochemistry on brain sec-
tions, with the majority of protein expression observed in the
cerebral cortex, hippocampus, cerebellum, and olfactory
bulb. We also note a signiﬁcant level of expression in the
spinal cord, and speciﬁcally in the large neuronal bodies
found in the dorsal root ganglia. Within the brain regions,
PIP4K was expressed in speciﬁc neuronal cell populations,
and expression in granule cells and neuroglia was negligible.
These neurons could be identiﬁed as Purkinje cells in the
cerebellum, pyramidal cells in the hippocampus, and cells in
the mitral cell layer of the olfactory bulb. The expression of
PIP4K was also seen to be homogeneous in these areas and
not restricted to neuronal populations within speciﬁc hip-
pocampal subﬁelds or cerebellar compartments. The popula-
tion of PIP4K-positive neuronal cells in the cerebral cortex
and spinal cord was a deﬁned subset, based on our marker
studies, and requires further characterization.
PIP4K and neuronal development
Gene ontology (GO) terms (Ashburner et al., 2000) for
neuron-enriched gene expression in the CNS suggest that
there are categories involved with synaptic function, neuronal
cell signalling and metabolism, neurogenesis, and neuronal
transport, including vesicle-mediated trafﬁcking (Lein et al.,
2007). Recent reports have also implicated PtdIns5P (Xie et
al., 2005) and PI-metabolizing enzymes (Coulson et al., 2008;
Polleux et al., 2002) in neurogenesis and neuronal develop-
ment and migration. Our results indicate that, in the develop-
ing postnatal mouse brain, PIP4K expression is ﬁrst ob-
served after P7 and is established at P14, a developmental
stage at which neurogenesis and neuronal migration and dif-
ferentiation of Purkinje cells in the cerebellum, pyramidal cells
in the hippocampus, and mitral cells in the olfactory bulb
should be completed (Finlay and Darlington, 1995; Hatten,
1999; Madalosso et al., 2005). The lack of observed PIP4K
expression before postnatal stage P7 would suggest that this
PIP4K does not participate in phosphoinositide-regulated
events prior to this, but this has yet to be determined for
embryonic developmental stages.
PIP4K subcellular distribution and neuronal
function
The expression of PIP4K in a neuronal subpopulation from
P14 to adult would suggest that this enzyme might have a
speciﬁc involvement with neuronal function. Our observation
that PIP4K is present in large neuronal cell bodies, as well as
throughout their dendritic projections, would suggest a cen-
tral rather than a peripheral role. Our results also suggest that,
as with specialized cells in the mammalian nephron (Clarke et
al., 2008), PIP4K is localized to a vesicular cytoplasmic com-
partment that is partially coincident with components of the
endomembrane system. The absence of a recognized signal
peptide within the PIP4K sequence suggests that this pro-
tein would not be directly targeted to the ER or plasma mem-
brane, in accordance with our colocalization studies, and
hence may be associated with the external surface of a traf-
ﬁcking compartment (Alvarez et al., 2001). Our evidence of
partial colocalization of PIP4K with Golgi complex and en-
dosomal markers may suggest that this protein is associated
with speciﬁc transport vesicles that shuttle between different
endosomal organelles. The presence of PtdIns5P in trafﬁcking
vesicles is suggested by the substrate preference of a Golgi-
localized lipid phosphatase, PLIP (Merlot et al., 2003), and the
involvement of this phosphoinositide with vesicle transloca-
tion to the plasma membrane (Sbrissa et al., 2004). Further-
more, a recent comparative genomics study suggests that
PtdIns5P is regulated by protein complexes, involving a ki-
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PIP4K associates with a vesicular compartment that partially colocalizes with components of the endomembrane system. Expression of GFP-
tagged PIP4K in HeLa cells and mild permeabilization with digitonin (A–L) indicated a vesicular cytoplasmic pool of PIP4K that partially colocalized
with the Golgi marker GM130 (D–F) and the endosomal markers EEA1 (G–I) and mannose-6-phosphate receptor (M6PR; J–L) but not with the -ergic
marker p115 (A–C). Results observed after permeabilization with Triton X-100 (M–X) suggested that the main pool of PIP4K did not remain localized
to any of these markers (O,R,U,X). Scale bars  10 m in C (applies to A–C); 10 m in F (applies to D–F); 10 m in I (applies to G–I); 10 m in L (applies
to J–L); 10 m in O (applies to M–O); 10 m in R (applies to P–R); 10 m in U (applies to S–U); 10 m in X (applies to V–X).Figure 14.
Expression of PIP4K in the developing mouse brain. Immunohistochemical staining of mouse brain sections at different postnatal development
stages (P1–P28 days after birth) indicated the levels of PIP4K (green) detected in three different regions; cerebellum (A–E), hippocampal ﬁeld
CA3 (F–J), and olfactory bulb (K–O). Brain regions are pictured in the same orientation, and images are representative of two animals at each
developmental stage. mo, Molecular layer; pu, Purkinje layer; gr, granular layer (cerebellum); so, stratum oriens; sp, stratum pyramidale; sr,
stratum radiatum; sl, stratum lacunosum-moleculare (hippocampal formation); pl, plexiform layer; mi, mitral cell layer; gr, granule layer (olfactory
bulb). Scale bars  50 m. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]nase such as PIP4K, and has a role in membrane trafﬁcking
(Lecompte et al., 2008). PIP4K has also been associated with
actin remodelling during endocytic transport (Pelkmans et al.,
2005), suggesting that modiﬁcation of the PtdIns5P signal or
synthesis of PtdIns(4,5)P2 in a speciﬁc compartment might
have a role in this process. Recombinant PIP4K has no
detectable intrinsic kinase activity, although enzyme recov-
ered from a mammalian expression system is seen to be
active (Itoh et al., 1998). Our previous study suggested that
this activity could also be attributable to the ability of PIP4K
to associate with other, more active PIP4K isoforms (Clarke et
al., 2008) and that PIP4K might function to recruit this activity
to a speciﬁc cellular compartment. It should also be noted that
there have been several recent reports of the regulation of
various membrane channels by phosphoinositides (for re-
views see Gamper and Shapiro, 2007; Suh and Hille, 2005),
which could be coincident with delivery of the channel com-
plexes to the plasma membrane. Although there is as yet no
direct evidence for the involvement of PIP4K in these pro-
cesses, it remains an intriguing possibility that the PIP4Ks are
involved in neuronal function via one of these mechanisms.
The restricted expression of PIP4K in the CNS may be
signiﬁcant within the context of the specialized function of
different neurons. It remains to be seen whether the role of
phosphoinositide signalling involving this kinase is a common
feature to the population of neurons that express it or whether
there are different, neuron-speciﬁc functions of PtdIns5P, or
localized pools of PtdIns(4,5)P2, in these cells.
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